Geoffrey Guy | |
|---|---|
 Geoffrey Guy at the Royal Society of Medicine (2024) | |
| Born | 1954 (age 69–70) Stanmore, Middlesex, England |
| Nationality | British |
| Education | |
| Known for | Co-founder GW Pharmaceuticals |
| Medical career | |
| Research | |
| Notable works | The Medicinal Uses of Cannabis and Cannabinoids (2004) |
Geoffrey William Guy (born 1954) is a British pharmacologist, physician, businessman and academic, who co-founded GW Pharmaceuticals and has developed treatments using compounds found in cannabis, which are the first cannabis-based medicines approved by and available on the British National Health Service (NHS).
In the 1980s and 1990s he was successful in the opiate painkiller business, and held appointments at the Laboratoires Pierre Fabre and the Napp laboratories. He was a member of the editorial board of the Journal of Cannabis Therapeutics, and has authored, contributed to and edited over 200 clinical studies and several books including The Medicinal Uses of Cannabis and Cannabinoids (2004).